GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography

Clinical trial NCT06223204 · COMPLETED

Trial details

NCT number: NCT06223204
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2024-01-31
Primary completion: 2024-04-10
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.